Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses
about
sameAs
Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activityRibavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivoRecent progress in antiviral chemotherapy for respiratory syncytial virus infections.High-throughput screening-based identification of paramyxovirus inhibitorsCancer and virus leads by HTS, chemical design and SEA data miningUse of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokineticsInhibitors of measles virus.Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult PatientsNon-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: Synthesis and in vitro evaluation.Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus.Emerging drugs for respiratory syncytial virus infection.Measles control--can measles virus inhibitors make a difference?Strong inhibition of betanodavirus replication by ribavirin targeting RNA-dependent RNA polymerase.Pharmacokinetics, efficacy prediction indexes, and residue depletion of ribavirin in Atlantic salmon's (Salmo salar) muscle after oral administration in feed.In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus.Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.Mode of antiviral activity of water soluble components isolated from Elfvingia applanata on vesicular stomatitis virus.Macromolecular prodrugs for controlled delivery of ribavirin.Ribavirin up-regulates IL-12 p40 gene expression and restores IL-12 levels in Leishmania-treated PBMCs.Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated PatientRibavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
P2860
Q24678611-730B4E11-667C-49ED-BCD1-346910AEA3EBQ27480732-3704E823-6FF3-42D6-8D8B-CF60C88379D3Q31521336-5B76D1FC-303E-4A02-9940-38EA1FAB5914Q33351623-FBFB313F-2205-426C-A774-929783AF8438Q33508912-4FB5A3FF-66D3-4493-B67D-752FD3489769Q33979339-D953A1FF-823C-4E00-8527-DDC788782370Q34216124-D634BE7B-B820-44BF-B999-9AE2B87F0EC5Q34222907-066193F8-D233-4D5F-A84E-BDA77B101899Q35842266-654C7A5A-2835-44D9-84B2-377400B49F10Q36008978-F0FDEF23-A764-4631-B22B-E0CA9C465A2FQ36178562-227AC9E2-9770-4EAA-BC00-1E9EE649475FQ36280339-E057F7EC-9ED1-46C3-99C6-EF38CF8689EAQ36984136-63BFA532-1DEF-4F3B-91AF-44F8D1FE7384Q37018993-14611B3A-A464-40D1-B17E-1AA8B547526BQ37121907-52C2A4D7-503F-4079-A6A6-735FF7DA0E56Q37250650-4B170AB4-E1B2-40F0-8861-6BE0AA5696EBQ37570103-B3F8A1DB-CFD1-4556-9C18-9A6A0E405E69Q38860257-0A2109AE-FEED-4F4A-BB2C-CA5A2BE6E9DBQ40761586-9C84C972-C3CF-4CE6-BF13-76DCD95D6857Q41684504-DDEACB92-3938-4501-A659-7FEE35FDD590Q42113871-EB84F1D5-3A6A-4B6A-8023-AB7CBB0A4D80Q43724047-B45A4D4E-BCB1-419B-92D9-58B56A98A5ADQ44091038-51AAA128-F7C6-41C8-8C40-0A073B7AC667Q45738358-AD6ABAD2-5272-48F0-AC3B-6EA32009D3D0Q50547116-3E9A2523-72B6-40B3-8E70-7564D95EE172Q50577648-EF1B360E-8842-4982-95BF-EACAB5E62485Q50585994-75D2E53C-702A-4B97-9B5D-A13B315068A5Q58573668-A56CD6A9-922E-4D13-9345-92BAD3667616Q59049605-4B4A6E6D-49E9-4C6B-AACD-61E5A8B5E648
P2860
Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@ast
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@en
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@nl
type
label
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@ast
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@en
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@nl
prefLabel
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@ast
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@en
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@nl
P2093
P2860
P356
P1476
Antiviral activities of ribavi ...... ral ortho- and paramyxoviruses
@en
P2093
H Oshitani
K Nakamura
Y Numazaki
P2860
P356
10.1128/AAC.36.2.435
P407
P577
1992-02-01T00:00:00Z